Drugmaker Can't Extend IP Protections For Contraceptive
A London court has refused to grant a Spanish pharmaceutical business extended patent protections for its contraceptive drug, ruling Friday that a marketing authorization already existed for the drug....To view the full article, register now.
Already a subscriber? Click here to view full article